Predictive genetic counseling service is a process of consulting physicians and consultants to discuss and discuss all the problems faced by their families in terms of the cause, genetic mode, diagnosis, treatment, prevention, recurrence risk, etc., and finally make appropriate countermeasures and choices, and implement them with the help of consulting physicians, so as to achieve the prevention and control effect.
The global market for Predictive Genetic Counseling Service is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Predictive Genetic Counseling Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Predictive Genetic Counseling Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Predictive Genetic Counseling Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Predictive Genetic Counseling Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Predictive Genetic Counseling Service players cover F. Hoffmann-La Roche Ltd, Abbott, Thermo Fisher Scientific Inc, Agilent Technologies, Inc and Bio-Rad Laboratories, Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Predictive Genetic Counseling Service market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Predictive Genetic Counseling Service market, with both quantitative and qualitative data, to help readers understand how the Predictive Genetic Counseling Service market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Predictive Genetic Counseling Service market and forecasts the market size by Type (Premarital Examination Service, Parent Child Identification Service and Antenatal Examination Service), by Application (Adult and Children.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Premarital Examination Service
Parent Child Identification Service
Antenatal Examination Service
Single Gene or Polygene Disease Diagnosis Service
Segmentation by application
Adult
Children
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
F. Hoffmann-La Roche Ltd
Abbott
Thermo Fisher Scientific Inc
Agilent Technologies, Inc
Bio-Rad Laboratories, Inc
Illumina, Inc
QIAGEN
Myriad Genetics, Inc
Pathway
Siemens
Genomic Health, Inc
Admera Health
DeCODE Genetics
BGI Group
Chapter Introduction
Chapter 1: Scope of Predictive Genetic Counseling Service, Research Methodology, etc.
Chapter 2: Executive Summary, global Predictive Genetic Counseling Service market size and CAGR, Predictive Genetic Counseling Service market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Predictive Genetic Counseling Service revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Predictive Genetic Counseling Service revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Predictive Genetic Counseling Service market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including F. Hoffmann-La Roche Ltd, Abbott, Thermo Fisher Scientific Inc, Agilent Technologies, Inc, Bio-Rad Laboratories, Inc, Illumina, Inc, QIAGEN, Myriad Genetics, Inc and Pathway, etc.
Chapter 14: Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Predictive Genetic Counseling Service. Industry analysis & Market Report on Predictive Genetic Counseling Service is a syndicated market report, published as Global Predictive Genetic Counseling Service Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Predictive Genetic Counseling Service market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.